Ende Eric J
- SEC CIK
- 0001494386
No open-market purchases or sales filed in the past year.
Current role at each company
- AVDL Avadel Pharmaceuticals PLCDirectoras of Feb 12, 2026
- MTNB Matinas BioPharma Holdings, Inc.Directoras of Nov 3, 2023
- NBSE NeuBase Therapeutics, Inc.Directoras of Sep 12, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ende Eric J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVDL Avadel Pharmaceuticals PLC
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2025 (view filing) | Jan 13 | 1 day | Ende Eric JDirector | PPurchase | +30.0K | $7.84 | +$235.2K | +16.8%208.9K after | |
| May 19, 2023 (view filing) | May 18 | 1 day | Ende Eric JDirector | PPurchaseADSs | +13.0K | $13.93 | +$181.1K | +8.4%167.9K after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Ende Eric JDirector | PPurchaseADSs | +20.0K | $7.80 | +$156.0K | +14.8%154.9K after | |
| Jun 1, 2022 (view filing) | May 31-Jun 1 | 1 day | Ende Eric JDirector | PPurchaseADSs | +35.0K | $2.22 | +$77.8K | +35.0%134.9K after | 2 lots |
| May 31, 2022 (view filing) | May 27 | 4 days | Ende Eric JDirector | PPurchaseADSs | +15.0K | $2.45 | +$36.8K | +17.7%99.9K after |